Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
|
|
- Arnold Sutton
- 6 years ago
- Views:
Transcription
1 Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
2 Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers clients comprehensive legal expertise paired with a practical understanding of commercial realities. With a multidisciplinary and integrated global practice, we provide our healthcare and life sciences clients with leading edge transactional advice and litigation expertise that are crucial to the successful execution and consummation of deals and the resolution of disputes. As the following pages demonstrate, Sullivan & Cromwell s Healthcare and Life Sciences Group has had the privilege of working on a number of transactions that have transformed the healthcare industry. We are grateful that our clients have trusted us with many of the industry s most significant matters. We look forward to working with existing and new clients and bringing to bear our industry expertise and experience in what promises to be another exciting year in dealmaking as companies continue to position themselves strategically in an ever-evolving industry. Keith A. Pagnani Co-head of the Healthcare and Life Sciences Group Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. 1
3 Timeline of S&C s Headline Transactions Recently, S&C advised on several major healthcare M&A transactions. Pharmasset S&C client Pharmasset (U.S.) completes its $11 billion acquisition by Gilead Sciences (U.S.) Medco Health Solutions S&C client Medco Health Solutions (U.S.) completes its $34.3 billion acquisition by Express Scripts (U.S.) Veritas Capital S&C client Veritas Capital (U.S.) completes its $1.25 billion acquisition of the healthcare business of Thomson Reuters (U.S.) Bayer S&C client Bayer HealthCare LLC (U.S.), a subsidiary of Bayer AG (Germany), announces its proposed $1.2 billion acquisition of Schiff Nutrition International (U.S.) Valeant Pharmaceuticals S&C client Valeant Pharmaceuticals (Canada) completes its $2.6 billion acquisition of Medicis (U.S.) Bayer S&C client Bayer AG (Germany) completes its acquisition of Conceptus, Inc. (U.S.) for approximately $1.2 billion January February March April May June July August September Amgen S&C client Amgen (U.S.) completes its $1.16 billion acquisition of Micromet (U.S.) * S&C represented the financial adviser to Zoll Medical Corporation ** S&C represented the financial adviser to Johnson & Johnson ZOLL Medical* ZOLL Medical Corporation (U.S.) completes its $2.21 billion acquisition by Asahi Kasei Corporation (Japan) Johnson & Johnson** Johnson & Johnson (U.S.) completes its $21.3 billion acquisition of Synthes (Switzerland) October November December January February March April May June July United Healthcare Group S&C client UnitedHealth Group (U.S.) completes its $4.9 billion acquisition of Amil Participações S.A. (Brazil) Perrigo Company S&C client Perrigo Company (U.S.) announces its proposed approximately $8.6 billion acquisition of Elan Pharmaceuticals (Ireland) Medco s purchase by Express Scripts for roughly $34 billion won Americas Corporate Deal of the Year among mergermarket and the Financial Times Americas M&A Awards. Partners James Morphy and Matthew Hurd led the S&C team advising Medco. MERGERMARKET AND THE FINANCIAL TIMES, JANUARY 2012 In its monthly Big Deals column, The American Lawyer included Pharmasset s acquisition by Gilead Sciences for $11 billion Gilead s largest acquisition ever. Partners Matthew Hurd and Krishna Veeraraghavan led the team advising Pharmasset. THE AMERICAN LAWYER, FEBRUARY 2012 The Wall Street Journal recognized UnitedHealth Group s $4.9 billion acquisition of Amil as...the highest-profile commitment so far by a U.S. healthcare firm to foreign operations... The American Lawyer named it the Global M&A Deal of the Year: Brazil. Partner Keith Pagnani led the S&C team advising UnitedHealth. THE WALL STREET JOURNAL, OCTOBER 2012 AND THE AMERICAN LAWYER, JULY 2013 The Daily Journal named Alison Ressler to its list of Top Women Lawyers of 2013, recognizing her for her work on behalf of a number of high-profile clients, including advising Valeant Pharmaceuticals on several deals. THE DAILY JOURNAL, MAY
4 Other Healthcare Highlights In addition, S&C was involved in the following transactions, which showcase our experience working with a diverse set of participants in the healthcare and life sciences industry. From representing pharmaceutical, biotechnology and life sciences companies, to working directly with leading medical information system and technology specialists, as well as healthcare services and providers, Sullivan & Cromwell s industry experience is vast. Sample Representations of Principals: Amgen Counsel to Amgen (U.S.) in: its $415 million acquisition of decode Genetics (Iceland) its $315 million acquisition of Kai Pharmaceuticals (U.S.) CONMED Counsel to CONMED (U.S.) in: its $22.5 million acquisition of Viking Systems (U.S.) its $147 million transaction with Musculoskeletal Transplant Foundation (MTF) (U.S.) to obtain (i) exclusive, worldwide promotion rights with respect to MTF s human tissue grafts for use within the field of sports medicine, and (ii) an exclusive, worldwide license to MTF s platelet-rich plasma technology and products Ipsen Pharma Counsel to Ipsen Pharma (France) in its global license, development and commercialization agreements for two investigational drugs in late-stage development for hemophilia with its strategic partner, Inspiration Biopharmaceuticals, Inc. (U.S.) Lightyear Capital Counsel to Lightyear Capital (U.S.) in its acquisition of Paradigm Acquisition Corp. (U.S.) from Sterling Partners (U.S.) for an undisclosed amount Optimer Pharmaceuticals Counsel to Optimer Pharmaceuticals (U.S.) in its proposed acquisition by Cubist Pharmaceuticals (U.S.) Paion Counsel to Paion (Germany) in the sale of its remaining rights in a Phase III compound called Desmotephlase to H. Lundbeck (Denmark) for $27 million Stryker Counsel to Stryker Corporation (U.S.), who jointly announced with Trauson Holdings Company Limited (China), a conditional voluntary cash offer to acquire all the shares and share options of Trauson for a maximum total consideration of approximately $764 million UnitedHealthcare Counsel to UnitedHealthcare (U.S.), a UnitedHealth Group company, in its acquisition of XLHealth Corp. (U.S.) Valeant Pharmaceuticals Counsel to Valeant Pharmaceuticals (Canada) in: its $112.5 million acquisition of the business relating to the Visudyne product (U.S.) from QLT, Inc. (Canada) its acquisition of Eyetech, Inc. (U.S.) for an undisclosed amount Sample Representations of Financial Advisers: American Dental Partners Counsel to independent financial adviser to the special committee of the board of directors of American Dental Partners, Inc. (ADPI) (U.S.) in ADPI s acquisition by funds affiliated with JLL Partners (U.S.) for approximately $400 million Auxilium Pharmaceuticals Counsel to financial adviser to Auxilium Pharmaceuticals, Inc. (U.S.) in its $635 million acquisition of Actient Holdings LLC (U.S.) BioMimetic Therapeutics Counsel to financial adviser to BioMimetic Therapeutics (U.S.), in its $140 million business combination with Wright Medical Group (U.S.) EKR Therapeutics Counsel to financial adviser to EKR Therapeutics (U.S.) in its $150 million acquisition by Cornerstone Therapeutics (U.S.) Medica HealthCare Plans Counsel to financial adviser to Medica HealthCare Plans (U.S.) in its acquisition by United HealthCare Services (U.S.), a subsidiary of UnitedHealth Group (U.S.), for an undisclosed amount For the second year in a row, the National Association of Corporate Directors (NACD) named Frank Aquila to its Directorship 100 a list of the 100 most influential people in corporate governance and inside the boardroom. Mr. Aquila advises numerous clients in this regard, including Optimer Pharmaceuticals and long-time client, Amgen. NACD DIRECTORSHIP, NOVEMBER
5 Healthcare and Life Sciences Practice S&C s Longstanding History as a Leader in Healthcare M&A Sullivan & Cromwell offers clients comprehensive legal expertise paired with a practical understanding of commercial reality. Our pragmatic approach and multidisciplinary and integrated global practice allow us to provide our healthcare and life sciences clients with a full range of legal services. Clients benefit not only from our understanding of the complexities of the industry but also from our market-leading experience and strength in M&A, capital markets, litigation, real estate, tax and intellectual property, where we partner with clients to help them shape and carry out their strategic goals. S&C has played a leading role in the consolidation of the healthcare industry, advising on eight of the ten largest healthcare M&A deals to date. ACQUIRER TARGET DATE VALUE ($ millions) Pfizer (U.S.) Warner-Lambert (U.S.) ,771 Glaxo Wellcome* (U.K.) SmithKline Beecham (U.K.) ,775 Sanofi-Synthelabo (France) Aventis* (France) ,657 Pfizer (U.S.) Wyeth (U.S.) ,480 Pfizer (U.S.) Pharmacia* (U.S.) ,704 Ranked as a first tier firm within Healthcare: life sciences, Sullivan & Cromwell LLP brings strength from its capital markets and M&A work to the life sciences sector, where it works prolifically for many mid-sized and large pharmaceutical, biotech and diagnostics manufacturers. US LEGAL 500, 2011 One of the world s finest corporate/m&a outfits, Sullivan & Cromwell s healthy balance of midsized and high-end deals ensures that it continues to be a market leader irrespective of the state of the economy. CHAMBERS USA, 2010 Novartis (Switzerland) Alcon* (U.S.) ,425*** Roche Holding** (Switzerland) Genentech (U.S.) ,695 Merck (U.S.) Schering-Plough** (U.S.) ,704 Express Scripts (U.S.) Medco Health Solutions* (U.S.) ,306 Investor Group (U.S.) HCA (U.S.) ,147 Source: Thomson Reuters, December 5, 2012 * Representing the company identified ** Representing the financial adviser to the company identified *** Aggregate value of three-step acquisition ultimately consummated in 2011 S&C represented HCA management and Frist family Industry Sector Experience Pharmaceuticals (Branded and Generics) Medical Information Systems and Technology Winner of Acquisition International s U.S. Life Sciences Law Firm of the Year 2011 award. ACQUISITION INTERNATIONAL LEGAL AWARDS, 2011 Pharmaceutical Benefits Management Biotechnology and Life Sciences/ Biologics Medical Devices and Diagnostics Healthcare Services and Providers Health Insurance (Governmentsponsored and Private) Real Estate 6 7
6 Practice Contacts Francis J. Aquila Nader A. Mousavi Palo Alto Garrard Beeney Keith A. Pagnani Steven J. Elliott Alison S. Ressler Los Angeles Robert J. Giuffra, Jr George J. Sampas Matthew G. Hurd Melissa Sawyer Stephen M. Kotran Karen Patton Seymour Eric Krautheimer Los Angeles Spencer F. Simon Palo Alto James C. Morphy Krishna Veeraraghavan
7 new york. washington, d.c.. los angeles. palo alto london. paris. frankfurt tokyo. hong kong. beijing. melbourne. sydney
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationHealthcare and Life Sciences Group. Mergers & Acquisitions
Healthcare and Life Sciences Group Mergers & Acquisitions Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationCorwin v. KKR Financial Holdings LLC
Delaware Supreme Court Affirms That an Uncoerced and Fully Informed Disinterested Stockholder Vote Reduces the Standard of Review in a Merger Without a Controlling Stockholder to Business Judgment In an
More informationU.S. Mergers and Acquisitions
U.S. Mergers and Acquisitions Industry depth Notable quotes Addressing your needs At the forefront of industry-specific issues, ranging from unique compliance / risk issues to industrydriven transaction
More informationShareholder Proposal to Separate Roles of Chair and CEO Fails at JPMorgan by a Wide Margin
Shareholder Proposal to Separate Roles of Chair and CEO Fails at JPMorgan by a Wide Margin Large Majority of Votes Cast Against the Proposal; Reflects Thoughtful Shareholder Consideration of Actual CEO
More informationTWO NAMES. ONE COMMITMENT TO EXCELLENCE.
MOFO LONDON 2017 All That + Mojo TWO NAMES. ONE COMMITMENT TO EXCELLENCE. Morrison & Foerster is a global firm with exceptional credentials. Our name is synonymous with a commitment to client service that
More informationBe inspired. Your future with Orrick in Asia
Be inspired Your future with Orrick in Asia Why Join Orrick? Let us give you a few reasons We are a strong and expanding international firm Orrick has more than 1,100 lawyers in 25 offices worldwide. Over
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationDorsey A Global Business Law Firm
London Real Estate Dorsey A Global Business Law Firm 2 Dorsey is an international firm with over 550 lawyers in Europe, North America and Asia. Some of the world s most successful companies count on Dorsey
More informationWILSON SONSINI GOODRICH & ROSATI
WILSON SONSINI GOODRICH & ROSATI IS PLEASED TO ANNOUNCE THAT THE FOLLOWING ATTORNEYS HAVE BECOME PARTNERS AT THE FIRM. Troy Foster Corporate & Securities, Palo Alto Jessica L. Margolis Litigation, New
More informationCannabis Practice Group
Cannabis Practice Group McMillan LLP Vancouver Calgary Toronto Ottawa Montréal Hong Kong Cannabis mcmillan.ca Practice Group 1 Medical cannabis is booming and McMillan is at the forefront of developments
More informationLife Sciences. An evolving industry: Today s clusters creating tomorrow s breakthroughs. New Jersey JLL Research
Life Sciences New Jersey 2017 An evolving industry: Today s clusters creating tomorrow s breakthroughs JLL Research 2 New Jersey Over the course of the past 130 years, the pharmaceutical/life sciences
More informationDaryn A. Grossman. Proskauer.com. Partner. New York
Contact Daryn A. Grossman Partner New York +1.212.969.3665 dgrossman@proskauer.com Daryn A. Grossman is co-chair of Proskauer s global Corporate Department. She serves as the head of the Life Sciences
More informationAmsterdam. allenovery.com
Amsterdam 2 Allen & Overy Amsterdam Companies today have to be able to respond to global trends while still building on strong, local foundations. As a truly global firm, with strong attachment to our
More informationSebastian Burckhardt
Sebastian Burckhardt Dr., M.C.J. Attorney at Law and Civil Law Notary Partner Languages: German, English, French, Italian Contact: +41 58 211 33 47, sburckhardt@vischer.com General Due to his interest
More informationMara H. Rogers, Partner Norton Rose Fulbright
Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers
More informationPurvi B. Maniar Member of the Firm
Purvi B. Maniar Member of the Firm New York 250 Park Avenue New York, New York 10177 Tel: 212-351-3757 Fax: 212-878-8600 St. Louis Tel: 314-395-2775 pmaniar@ebglaw.com PURVI B. MANIAR is a Member of the
More informationHow attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners
How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? M ost
More informationLatin America. Pillsbury Winthrop Shaw Pittman LLP pillsburylaw.com
Latin America Pillsbury Winthrop Shaw Pittman LLP pillsburylaw.com Latin America Practice Pillsbury Winthrop Shaw Pittman LLP Overview Decades of Experience in Latin America Pillsbury s Latin America practice
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationRoschier at a glance. Premier legal services in the Nordic region
Roschier Press kit Roschier at a glance 2 (5) A leading law firm in the Nordic region Consistently recognized as a leader by regional and international ranking institutions and legal directories Active
More informationPATENT ATTORNEYS TRADE MARK ATTORNEYS
PATENT ATTORNEYS TRADE MARK ATTORNEYS INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need
More informationEuropean companies outpace American counterparts in R&D investment growth for the first time in five years
IP/08/1504 Brussels, 15 October 2008 European companies outpace American counterparts in R&D investment growth for the first time in five years R&D investment by EU companies has increased by 8.8% compared
More informationAsia Pacific UK Cross border transactions. Corporate Finance PRECISE. PROVEN. PERFORMANCE.
Asia Pacific UK Cross border transactions PRECISE. PROVEN. PERFORMANCE. Cross border transactions Our services Moore Stephens global network of offices allows us to combine expert knowledge and advice
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
More information2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region. Intellectual Property Protecting Your Assets in a Volatile Market
2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region Intellectual Property Protecting Your Assets in a Volatile Market Thursday, October 1, 2015 (2:45 p.m. 3:15 p.m.) Presented
More informationIntellectual Property
Intellectual Property 1 Overview In a progressively uncertain economy, counterfeit products are becoming more prevalent particularly in Vietnam. Therefore, companies should be increasingly vigilant in
More informationPromoting Foreign Direct Investment in The United States. Christopher Clement International Investment Specialist Invest in America
Promoting Foreign Direct Investment in The United States Christopher Clement International Investment Specialist Invest in America FDI in the U.S. Economy 5.2 million $40 billion $55 billion $190 billion
More informationAverage M&A Deal Size at Highest Level Since 2004
CONTACTS Ben Veghte NVCA 1.703.778.9292 bveghte@nvca.org Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MAINTAINS MOMENTUM WITH BEST QUARTER
More informationTECH START-UP CONNECTING ACROSS GEOGRAPHIES
#ML15MayRathon TECH START-UP CONNECTING ACROSS GEOGRAPHIES Andrew Ray, Partner, Washington DC William Perkins, Partner, Boston James Chapman, Partner, Silicon Valley Joseph Statter, Managing Director,
More informationLife Sciences Outlook
Life Sciences Outlook Raleigh- 2013-2014 Mid-tier biotech and specialty pharmaceuticals drive demand Across North America, activity and demand within the life sciences industry seems to have shifted from
More informationLife Sciences Regulatory
Life Sciences Regulatory Pharmaceuticals 2018 2 Life Sciences Regulatory Pharmaceuticals 2018 Top ranked in Chambers and Legal 500 for Life Sciences, pharmaceuticals and biotechnology. Allen & Overy LLP
More informationFirm Overview. The firm includes 25 professionals, including 19 lawyers and 6 patent agents and technical specialists, of whom 10 hold Ph.D. degrees.
Firm Overview At Lahive, our thinking expands yours. Our lawyers and technical specialists practice at the cutting edge of intellectual property, with special expertise in biotechnology, chemistry, high
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
More informationPATENT ATTORNEYS TRADE MARK ATTORNEYS
PATENT ATTORNEYS TRADE MARK ATTORNEYS 02 INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationWOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview
Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context
More informationNOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA
Press release Baar, 28 January 2008 Attractive portfolio of investments in biotech and medical technology to be opened to the public HBM BioVentures announces further information of its planned IPO on
More informationOmeros Raises More Than $63 Million in Financing
Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,
More informationInternational Presence, Local Expertise. Introductory Presentation
International Presence, Local Expertise Introductory Presentation About GlobalM&A Partners Established in 1999 A partnership of 38 leading independent M&A firms Over 200 active dealmakers supported by
More informationFrançois G. Laugier's Representative Experience
François G. Laugier's Representative Experience Practice Area: International, Mergers & Acquisitions Key Issues: Acquisitions (For Buyer) Client Type: Foreign Publicly-Traded Naval Technology Company Description:
More informationMark Opashinov. Toronto education and year of call. profile
Toronto 416.865.7873 education and year of call Called to the Ontario bar - 1998 Osgoode Hall Law School, LLM - 2010 Queen's University, LLB - 1996 Queen's University, MA - 1993 University of Toronto,
More informationJean W. Frydman Partner
Jean W. Frydman Partner Princeton, NJ Tel: 609.895.6630 Fax: 609.896.1469 jfrydman@foxrothschild.com A former general counsel for multinational pharmaceutical companies and a multinational retail dietary
More informationStudy overview. The Global Biomedical Industry: Preserving U.S. Leadership
Presentation for: Voluntary Health Leadership Conference February 9, 2012 Rancho Bernardo Inn San Diego, CA Ross DeVol Chief Research Officer Milken Institute Study overview Part 1: Understanding the Factors
More informationVenture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010
CONTACTS Channa Brooks Tenor Communications for NVCA 1.302.368.2345 channa@tenorcom.com Daniel Billings Thomson Reuters 1.646 223 5985 daniel.billings@thomsonreuters.com Exit Activity Shows Improved Signs
More informationNasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd
Nasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd Get in touch Tel. (direct): +84 (8) 3824 0109 nasir.pkm@pwc.com Professional profile Nasir is a partner and the Legal Services Leader in Vietnam.
More informationP r e s e n t a t i o n. We are an independent and China-based corporate law firm. We make sure you successfully reach your goals in China.
P r e s e n t a t i o n We are an independent and China-based corporate law firm. We make sure you successfully reach your goals in China. 01 WHO WE ARE Corporate law firm Local approach Solution driven
More informationThe 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
More information1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp
1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Fenwick fenwick & west llp 1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Survey Introduction
More informationMining. Construction Family Offices. Life Sciences Life Sciences. Oil & Gas. Automotive. Mining. ealth Law. ommercial Finance. conomic Incentives
Litigation Human Resources Trusts & Estates Oil & Gas Oil & Gas Life Sciences Financial Services conomic Incentives Family Offices Life Sciences Business & Corporate Services Litigation Real Estate/Development
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More information2014 Global venture capital confidence survey results
2014 Global venture capital confidence survey results How confident are investors? August 13, 2014 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing
More informationSOLAR. Representing clients across the renewable energy industry. Troutman Sanders LLP. troutman.com
SOLAR Representing clients across the renewable energy industry What clients value Troutman Sanders served as counsel to over 5600 MWs of solar projects in 2016-2017. U.S. News Best Lawyers Our innovative
More informationHelping Businesses & Investors. Succeed Across Saudi Arabia
Helping Businesses & Investors Succeed Across Saudi Arabia Alnowaiser Law Firm was founded in 1996 and we have offices in Riyadh and Jeddah. Our firm is currently staffed with experienced professionals
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationJanuary Bob DeSutter Managing Director Co-Head of Health Care
January 2007 Dear Friends and Clients, For much of our 112 year history, serving innovative health care companies has been an important part of our mission at Piper Jaffray. Our goal is to be lead advisor
More informationPBI CYBERLAW UPDATE 2018
PBI CYBERLAW UPDATE 2018 Presented by Emily Lowe July 17, 2018 2018 Morgan, Lewis & Bockius LLP REGULATORY RESPONSE TO FACEBOOK/CAMBRIDGE ANALYTICA FINDINGS 2 Background Last March, Facebook admitted it
More informationwhen it comes to law OPERATIONAL EXPERIENCE Soody Tronson Managing Founder Phone Fax Woodside / Santa Clara
when it comes to law Soody Tronson Managing Founder OPERATIONAL EXPERIENCE soody@stlgip.com Phone 650.275.3913 Fax 866.325.7964 Woodside / Santa Clara www.stlgip.com matters By appointment only https://calendly.com/soody
More informationChambers USA 2016 Distinguishes 22 Katten Practices and 50 Attorneys
For Immediate Release May 27, 2016 Contact: 525 West Monroe Street Chicago, 60661 +1.312.902.5200 tel +1.312.902.1061 fax www.kattenlaw.com Jackie Heard +1.312.902.5450 jackie.heard@kattenlaw.com Kate
More informationPOST EVENT REPORT IP Life Sciences Exchange 2015
POST EVENT REPORT IP Life Sciences Exchange 2015 A vivid cross-section of present IP challenges, interwoven with opportunities to discuss present needs with solution providers. Deputy Head of IP Egis Pharmaceuticals
More informationMedtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year
www.pwc.com Medtech Slowdown Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year February 2014 2 PwC US venture capital funding for
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More information2009 Lateral Partner Hires. Manatt, Phelps & Phillips, LLP
2009 Lateral Hires Manatt, Phelps & Phillips, LLP Summary of 2009 Hires Advertising: Manatt is building the preeminent advertising practice. This year we hired the go-to players in advertising law, consumer
More informationthe practice of law the way it should be
at a glance A 200 attorney Firm with 50 partners in a single office where collaboration and collegiality are valued the practice of law the way it should be 100% attorney pro bono participation for over
More information- University of St. Gallen (M.A. HSG in Law, 2010) - London School of Economics and Political Science (LL.M., 2016)
David Weber M.A. HSG in Law, LL.M. Attorney at Law Senior Associate Languages: German, English, French Contact: +41 58 211 36 16, dweber@vischer.com General David Weber's practice focuses on banking and
More informationA conference hosted by ICC and CCPIT
International Industry and Commerce Intellectual Property Seminar Increasing Economic and Business Competitiveness Using Intellectual Assets 26 October 2012 - Intercontinental Hotel, Beijing A conference
More informationManatt Digital 2016 REPRESENTATIVE TRANSACTIONS AND CLIENTS
Manatt Digital 2016 REPRESENTATIVE TRANSACTIONS AND CLIENTS Turning optimism into opportunities. Acorn Technologies Series B Financing AktaryTech Counsel to Lead Investor AthliOS Company Formation and
More informationMedia and Entertainment. A guide to our offering
Media and Entertainment A guide to our offering We have wide-ranging experience across the media sector, with a client base comprising broadcasters, content providers, technology companies, publishers,
More informationPrograms for Academic and. Research Institutions
Programs for Academic and Research Institutions Awards & Recognition #1 for Patent Litigation Corporate Counsel, 2004-2014 IP Litigation Department of the Year Finalist The American Lawyer, 2014 IP Litigation
More informationDavid Jenny. General. Education
David Jenny Dr., LL.M. Attorney at Law Partner Languages: German, English, French Contact: +41 58 211 33 49, djenny@vischer.com General David Jenny has been advising and representing corporations since
More informationSeptember 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
More informationBreakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC
Breakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC Study overview Part 1: The Global Biomedical Industry: Understanding the
More informationHealthcare and Life Sciences
Healthcare and Life Sciences Introduction Uría Menéndez is an independent law firm that was founded in Madrid in 1946 by Professor Rodrigo Uría González. We currently have seventeen offices in Spain, Portugal,
More informationVENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE
CONTACTS Laura Cruz Tenor Communications for NVCA 1.917.406.7517 laura@tenorcom.com Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY KEEPS
More informationQ&A with Samira Salman
APRIL 2017 VOL. 5 ISSUE 122 R E P O R T Q&A with Samira Salman Founder of Salman Solutions. Principle Series: Family Office Insights sits down with Samira Salman to discuss successful deal structuring
More informationAutomotive Supply Industry Law
Automotive Supply Industry Law A Better Partnership Warner Norcross & Judd LLP 1 The speed at which your business grows depends upon the ability to anticipate what s around the curve. Our automotive attorneys
More informationVENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000
CONTACTS Laura Cruz Tenor Communications for NVCA 1.917.406.7517 laura@tenorcom.com Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN
More informationRoche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.
Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP
More informationRobert A. Greising Partner
Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising serves as a Partner
More informationStikeman Elliott at the IBA. Rome 2018 Visit stikeman.com/iba
Stikeman Elliott at the IBA Rome 2018 Visit stikeman.com/iba Our Team Patrick L. Benaroche (Page 2) Eric H. Bremermann (Page 2) Peter J. Cullen (Page 3) Philip J. Henderson (Page 3) Samaneh Hosseini (Page
More informationA GUIDE TO OUR SECTORS, SERVICES AND LOCATIONS
A GUIDE TO OUR SECTORS, SERVICES AND LOCATIONS CONNECTING ACROSS BORDERS NEW YORK MADRID LONDON PARIS HAMBURG FRANKFURT MUNICH MILAN GLOBAL OFFICE HEADS ATHENS George Paleokrassas BANGKOK Steven Burkill
More information$- Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
Great Lakes regional M&A update: Q2 2018 Aggregate Transaction Value ($ in millions) # of Middle Market Deals $3,500 100 $3,000 $2,500 $2,000 $1,500 $1,000 $500 $1,367 $1,506 29 32 $2,159 42 $2,497 $2,417
More informationAs our brand migration will be gradual, you will see traces of our past through documentation, videos, and digital platforms.
We are now Refinitiv, formerly the Financial and Risk business of Thomson Reuters. We ve set a bold course for the future both ours and yours and are introducing our new brand to the world. As our brand
More informationManaging your economic challenges and. managerial emergencies together
Managing your economic challenges and managerial emergencies together They relied on us PRIVATE EQUITY They relied on us - INDUSTRY They relied on us - SERVICES Our values Responsiveness A commitment to
More information2013 Global venture capital confidence survey results. How confident are investors?
2013 Global venture capital confidence survey results How confident are investors? August 14, 2013 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing
More informationRebekka Keller. General. Education. Teams
Rebekka Keller Dr. Attorney at Law Associate Languages: German, English, French Contact: +41 58 211 34 74, rkeller@vischer.com General Rebekka Keller is an attorney in the Corporate/M&A team of VISCHER.
More informationLIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationMergers and Acquisitions/ Private Equity. Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors. Attorney Advertising
Mergers and Acquisitions/ Private Equity Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors Attorney Advertising In every transaction, business perspective informs our legal strategy.
More informationIndustrial Investment in Research and Development: Trends and Prospects
MEMO/05/471 Brussels, 9 December 2005 Industrial Investment in Research and Development: Trends and Prospects The 2005 Key Figures for science, technology and innovation released last July showed EU R&D
More informationVenture Capital Report
Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included
More informationAttorney at Law and Civil Law Notary, Certified Specialist SBA Construction and Real Estate Law
Roland M. Müller Dr., LL.M. Attorney at Law and Civil Law Notary, Certified Specialist SBA Construction and Real Estate Law Partner Languages: German, English, French Contact: +41 58 211 33 00, rmueller@vischer.com
More informationTechnology Licensing
Technology Licensing Nicholas S. Vonortas Department of Economics & Center for International Science and Technology Policy The George Washington University Conference IPR, Innovation and Economic Performance
More informationLondon Office Graduate Recruitment
London Office Graduate Recruitment Trainee Solicitor and Summer Vacation Scheme Programmes Summer Vacation Scheme July 2019 Training Contracts September 2021 Who We Are 100 Years of combined business acumen
More informationHamilton Loeb. Washington, D.C. Practice Areas. Admissions. Languages. Education. Partner, Litigation Department
Hamilton Loeb Partner, Litigation Department hamiltonloeb@paulhastings.com Hamilton Loeb is a partner in the Litigation practice of Paul Hastings and is based in the firm s Washington, D.C., office. His
More informationVentureSource Europe -- 3Q 2014
Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a
More informationNEW YORK MARITIME FINANCE
NEW YORK MARITIME FINANCE HUGELY SOPHISTICATED PRACTICE FOCUSED ON THE REPRESENTATION OF FINANCIAL INSTITUTIONS AND MAJOR OWNERS AND OPERATORS IN ALL ASPECTS OF SHIPPING FINANCE INCLUDING RESTRUCTURING.
More information